pancreatic cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Common criteria: age 18-80; 2. Common criteria: Patient signs informed consent; 3. PDAC with diabetes Group: Pancreatic mass, clinically suspected pancreatic cancer; 4. PDAC with diabetes Group: At least one fasting blood glucose >6.1 mmol/L or 2-hour postprandial blood glucose >7.8 mmol/L; 5. PDAC with diabetes Group: At least one fasting or 2-hour postprandial blood glucose measurement in the previous 2-5 years that proves no diagnosis of diabetes 2 years ago; 6. Type 2 diabetes Group: Diagnosing type 2 diabetes; 7. Type 2 diabetes Group: Clinical evaluation indicates that insulin therapy is not currently required, and treatment is limited to diet control or the use of no more than one oral hypoglycemic agent. 8. Type 2 diabetes Group: Undiagnosed diabetes complications and able to complete an oral glucose tolerance test after clinical assessment.
Exclusion criteria
Exclusion criteria: 1. Allergic reaction to the glucose meter dressing; 2. Unable to wear or unable to obtain valid blood sugar test results; 3. Pancreatic cancer Group: Postoperative pathology ruled out pancreatic cancer; 4. Type 2 Diabetes Group: Acute complications such as ketoacidosis or hyperglycemic hyperosmolar state occur during wear, or changes in diabetes treatment drugs are needed due to changes in the condition during wear.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time In Range; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time Below Range;Time Above Range; | — |
Countries
China
Contacts
Peking Union Medical College Hospital